<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" 
	
>
<channel>
<title>Reuters: Health News</title>
<link>http://www.reuters.com</link>
<description>Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks.  Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.</description>
<image>
	<title>Reuters News</title>
	<width>120</width>
	<height>35</height>
	<link>http://www.reuters.com</link>
	<url>http://www.reuters.com/resources_v2/images/reuters125.png</url>
</image>
<language>en-us</language>
<lastBuildDate>Thu, 23 May 2013 13:28:39 -0400</lastBuildDate>
<copyright>All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. &#169; Reuters 2013</copyright>
<item>
		<title>Pfizer takes its shot at a vaccine for evasive superbug</title>


		<description>CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-pfizer-vaccine-idUSBRE94M05J20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-pfizer-vaccine-idUSBRE94M05J20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Thu, 23 May 2013 01:28:38 -0400</pubDate>
		</item>
<item>
		<title>GSK flu shot may raise adult narcolepsy risk: Finnish scientists</title>


		<description>HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc&#039;s H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland&#039;s National Institute for Health and Welfare said on Thursday.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-gsk-vaccine-narcolepsy-idUSBRE94M0FJ20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-gsk-vaccine-narcolepsy-idUSBRE94M0FJ20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Thu, 23 May 2013 07:13:34 -0400</pubDate>
		</item>
<item>
		<title>Saudi Arabia confirms another death from SARS-like virus</title>


		<description>DUBAI (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim region, bringing the total number of deaths in the kingdom to 17.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-coronavirus-idUSBRE94M0IN20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-coronavirus-idUSBRE94M0IN20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Thu, 23 May 2013 11:56:38 -0400</pubDate>
		</item>
<item>
		<title>New J&amp;J anti-depressant related to &#034;Special K&#034; party drug</title>


		<description>NEW BRUNSWICK, New Jersey (Reuters) - Johnson &amp; Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard medications.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-johnsonjohnson-investors-idUSBRE94M0J120130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-johnsonjohnson-investors-idUSBRE94M0J120130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Thu, 23 May 2013 11:37:37 -0400</pubDate>
		</item>
<item>
		<title>Merck&#039;s insomnia drug moves a step closer to U.S. approval</title>


		<description>WASHINGTON (Reuters) - Merck &amp; Co&#039;s experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-fda-merck-idUSBRE94L17Z20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-fda-merck-idUSBRE94L17Z20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Wed, 22 May 2013 21:02:13 -0400</pubDate>
		</item>
<item>
		<title>Novo Nordisk says obesity drug trial confirms weight loss</title>


		<description>COPENHAGEN (Reuters) - Denmark&#039;s Novo Nordisk, the world&#039;s biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-novonordisk-obesity-idUSBRE94M0VG20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-novonordisk-obesity-idUSBRE94M0VG20130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Thu, 23 May 2013 12:58:57 -0400</pubDate>
		</item>
<item>
		<title>Health officials probe deadly respiratory illness in Alabama</title>


		<description>BIRMINGHAM, Alabama (Reuters) - U.S. and state health authorities are investigating an unidentified respiratory illness that has killed two of 10 people hospitalized with it in Alabama since last week.</description>
		<link>http://www.reuters.com/article/2013/05/22/us-usa-alabama-illness-idUSBRE94L18R20130522?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/22/us-usa-alabama-illness-idUSBRE94L18R20130522?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Wed, 22 May 2013 17:49:53 -0400</pubDate>
		</item>
<item>
		<title>Senate committee advances drug compounding bill</title>


		<description>NEW YORK (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federal oversight for companies that compound and sell sterile drugs across state lines.</description>
		<link>http://www.reuters.com/article/2013/05/22/us-fda-drugs-legislation-idUSBRE94L1AU20130522?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/22/us-fda-drugs-legislation-idUSBRE94L1AU20130522?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Wed, 22 May 2013 18:58:37 -0400</pubDate>
		</item>
<item>
		<title>BTG says interventional medicine buys could boost sales to $1 bln</title>


		<description>LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion.</description>
		<link>http://www.reuters.com/article/2013/05/23/us-btg-idUSBRE94M0J320130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/23/us-btg-idUSBRE94M0J320130523?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Thu, 23 May 2013 08:07:11 -0400</pubDate>
		</item>
<item>
		<title>Online tool helps control blood pressure long term</title>


		<description>NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their pharmacists online had better blood pressure control a year after that service ended.</description>
		<link>http://www.reuters.com/article/2013/05/22/us-online-blood-pressure-idUSBRE94L17A20130522?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</link>
        <guid isPermaLink="true">http://www.reuters.com/article/2013/05/22/us-online-blood-pressure-idUSBRE94L17A20130522?feedType=RSS&amp;feedName=healthNews&amp;rpc=930</guid>
        <category>healthNews</category>
		<pubDate>Wed, 22 May 2013 17:13:39 -0400</pubDate>
		</item>
</channel>
</rss>

